- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07528950
Impact médico-économique de la télésurveillance Des Plaies Chroniques Avec Pixacare (IMETP)
Medico-Economic Impact of Telemonitoring Chronic Wounds With Pixacare
The healing of chronic wounds extends over several months and accounts for 3% of the healthcare budget. Care networks capable of managing chronic wounds are heterogeneous, insufficient, and poorly coordinated across the country.
The key levers identified to reduce the costs of chronic wound care are: reducing the number of consultations, shortening healing time, decreasing the weekly frequency of care, and enabling early management of complications through an alert system.
The Ministry of Health now aims to roll out telemonitoring into mainstream practice and to expand new telemonitoring structures to benefit new patients and new pathologies.
A review of the literature on telemedicine in general reveals numerous indicators confirming the strong potential of telemonitoring for chronic wounds to improve care efficiency.
It would allow specialized remote follow-up without adding workload for caregivers while reducing the number of in-person consultations. This expert oversight could lead to better-adapted treatments, resulting in faster healing and a reduced frequency of care.
Adverse developments and complications could also be detected and managed early through an alert system.
No controlled study using a digital tool with an alert system currently undergoing CE class IIa marking has yet effectively assessed the organizational and medical benefits of such telemonitoring for the management of chronic wounds. This is the objective of this research.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pierre GUERRESCHI
- Phone Number: +33 3 20 44 56 59
- Email: pierre.guerreschi@chu-lille.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patient aged over 18 years
- Suffering from a single chronic wound, meaning a wound of any origin evolving for more than 6 weeks (diabetic foot ulcer, leg ulcer, or pressure ulcer) Patient seen in a specialized consultation at Lille University Hospital (CHU de Lille) for wound management (Diabetology Department, Plastic Surgery Department)
- A home-based wound-care protocol planned at the time of inclusion
- Patients owning a smartphone or a tablet at home
- Patient willing to comply with all study procedures and duration
- Patient who has provided written informed consent to participate in the study
- Patient covered by national health insurance
Exclusion Criteria:
- Minor patient
- Pregnant woman
- Patient hospitalized at the time of inclusion (except for home hospitalization, HAD)
- Multiple wounds
- Wound not appearing flat in the photograph
- A home nurse (RN) who is already following a patient from one study group may not follow another patient from the other group (control or telemonitoring) Inability to receive informed information, inability to participate in the full duration of the study, lack of health insurance coverage, refusal to sign the consent form
- Patient under guardianship or curatorship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Telemonitoring of patients at home with chronic wounds. The home nurse (RN) performs dressing changes according to the care protocol. The patient takes photographs of the wound and completes the questionnaire using the Pixacare tele-upload application. If needed, a caregiver may assist the patient in taking the photographs. The study ends 16 weeks after randomization. |
elemonitoring of patients at home with chronic wounds. The home nurse (RN) performs dressing changes according to the care protocol. The patient takes photographs of the wound and completes the questionnaire using the Pixacare tele-upload application. If needed, a caregiver may assist the patient in taking the photographs. |
|
No Intervention: Control group
Conventional home follow-up of patients with chronic wounds. The home nurse (RN) performs dressing changes according to the care protocol. The study ends 16 weeks after randomization. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To demonstrate the superiority of a strategy based on home telemonitoring of patients, compared with a conventional follow-up strategy, in reducing the number of in-person consultations with specialized physicians among patients with chronic wounds
Time Frame: 16 weeks
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Wound-healing kinetics measured as the percentage reduction in wound area from baseline to end of study
Time Frame: 16 weeks
|
16 weeks
|
|
To compare, between the two groups (telemonitoring and conventional follow-up), the weekly frequency of dressing changes
Time Frame: 16 weeks
|
16 weeks
|
|
To compare, between the two groups (telemonitoring and conventional follow-up), the number of complications (infections, amputations).
Time Frame: 16 weeks
|
16 weeks
|
|
To compare, between the two groups (telemonitoring and conventional follow-up), the number and cumulative duration of hospitalizations related to the wound.
Time Frame: 16 weeks
|
16 weeks
|
|
Patient satisfaction score measured using a standardized digital satisfaction questionnaire integrated into the telemonitoring application
Time Frame: 16 weeks
|
16 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024_0237
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Wounds
-
PEMF Systems, Inc.Southern California Institute for Research and Education; VA Long Beach Healthcare...Not yet recruitingChronic Wounds
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
SerenaGroup, Inc.MDM Wound Ventures, LLCCompletedChronic Wounds | Acute WoundsUnited States
-
Woundchek Laboratories BVInnovate UK; Pennine Care NHS Foundation Trust; Greater Manchester Academic Health...Completed
-
SerenaGroup, Inc.Anacapa Technologies IncCompleted
-
Lohmann & RauscherRecruitingAcute and Chronic WoundsGermany
-
StimLabsActive, not recruitingChronic Wounds | Diabetic UlcersUnited States
-
Smith & Nephew, Inc.CompletedChronic WoundsUnited Kingdom
-
University Hospital Center of MartiniqueNot yet recruitingChronic WoundsMartinique
-
AntriaUnknownChronic WoundsUnited States